Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County.

Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County.

Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in the United States in January 2021. In February 2020, we collected qualitative data from 18 consumers and 23 clini...

Full description

Bibliographic Details
Main Authors: Oluwadamilola Jolayemi, Laura M Bogart, Erik D Storholm, David Goodman-Meza, Elena Rosenberg-Carlson, Rebecca Cohen, Uyen Kao, Steve Shoptaw, Raphael J Landovitz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0262926

Internet

https://doi.org/10.1371/journal.pone.0262926

Similar Items